Digital Biomarkers Market is projected to be worth over USD 22 billion by 2030

Roots Analysis has announced the addition of “Digital Solutions for Biomarkers Market, 2021-2030” report to its list of offerings.

Digital solutions for biomarkers are modern solutions that are capable of generating, collecting, and tracking medical data. From this data, digital biomarkers that offer insights into anatomical, physiological, and molecular events, and even behavior-related patterns in humans, have been acknowledged as viable inputs to understand, track, monitor and / or predict health-related outcomes. In the current pandemic, medical professionals are trying to identify digital biomarkers that can facilitate the successful screening / diagnosis of COVID-19 patients, remotely.

Key Market Insights

Over 45 digital solutions for biomarkers are currently available / under development

Over 70% of the aforementioned solutions are offered either as combinations of software applications and devices or as standalone software solutions, targeting more than 30 unique target indications.

Over 85% of digital solutions for biomarkers are intended for patient monitoring purposes

Such solutions are currently available / being developed to monitor various digital biomarkers associated with neurological disorders (22%), respiratory disorders (17%), and infectious disorders (15%). In fact, over 15% of these solutions are being extensively used for monitoring patients with COVID-19.

40 global events, focused on digital solutions for biomarkers, have been organized since 2016

Around 40% of these were conferences, involving more than 25 unique organizers. Close to 50% of such events have been / are being organized in the US.

Nearly USD 950 million invested by both private and public investors in this domain

~70% of the total capital raised by digital solutions for biomarkers developers was from venture capital funding, featuring the contributions of over 150 investors. In addition, over 65% was invested in companies focused on development of physiological / vocal digital biomarkers.


Partnership activity in this field has grown at a CAGR of over 60%, between 2016 and 2020

More than 65% of the reported deals were established in the last two years (since 2019), with the maximum activity being reported in 2020. Majority of the instances captured in the report were research and development agreements (24%) and product / technology integration agreements (15%). Further, more than 40% of these agreements have been signed for digital solutions for physiological biomarkers.

North America and Europe are anticipated to capture over 65% of the market share by 2030

The market in Asia-Pacific regions is anticipated to grow at a relatively faster pace (41.03%). In 2030, digital solutions capturing vocal biomarkers are likely to represent the largest market share, in terms of revenues from product sales (37%), followed by those intended to capture physiological biomarkers (32%) and idiosyncratic biomarkers (16%).  

Get Latest Market Insights: Digital Biomarkers Market is projected to be worth over USD 22 billion by 2030

Key Questions Answered

  • Who are the leading players engaged in the development of digital solutions for biomarkers?
  • Which are the popular therapeutic areas where digital biomarkers are currently relevant?
  • What kind of global level events related to digital biomarkers, have been organized in the recent past?
  • What is the trend of capital investments in the digital biomarkers market?
  • Which partnership models are most commonly adopted by stakeholders in this industry?
  • What is the tole of big pharma players engaged in this domain?
  • How has the COVID-19 pandemic impacted the digital biomarkers market?
  • What are the opportunities available for digital solutions for biomarkers in emerging markets?
  • How is the current and future opportunity likely to be distributed across key market segments?
  • What are the anticipated future trends related to digital solutions for biomarkers market?

The USD 22.6 billion (by 2030) financial opportunity within the digital solutions for biomarkers market has been analyzed across the following segments:

Content of Solution

  • Software Application + AI Support
  • Software Application + Device
  • Standalone Software Application
  • Other Contents of Solutions

Purpose of Solution

  • Diagnosis
  • Early Screening
  • Monitoring
  • Predictive Insights

Type of Biomarker

  • Cognitive Biomarkers
  • Idiosyncratic Biomarkers
  • Physiological Biomarkers
  • Vocal Biomarkers
  • Other Biomarkers

Therapeutic Areas

  • Autoimmune Disorders
  • Cardiovascular Disorders
  • Infectious Disorders
  • Mental Health Problems
  • Neurological Disorders
  • Respiratory Disorders
  • Substance Use Disorders
  • Others

Business Model

  • Business to Business (Healthcare Providers, Payers, Employers and Pharmaceutical Companies)
  • Business to Consumer (Patients and Caregivers)

Key Geographies

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa
  • Rest of the World

The report features inputs from eminent industry stakeholders, according to whom, digital biomarkers are soon likely to witness increased adoption given their broad scope of applications and the availability of technologies that enable such biological inputs to be remotely identified and processed. The report includes detailed transcripts of the discussions held with following industry experts:

  • Edouard Gasser (Co-Founder and Chief Executive Officer, Tilak Healthcare)
  • Michael Seggev (Chief Commercial Officer, Vocalis Health)

The research covers brief profiles of key players engaged in the development of digital solutions for biomarkers; other popular industry players featured in the report include:

  • Akili Interactive
  • AiCure
  • Cogito Corp
  • Janssen Pharmaceuticals
  • Huma
  • Mindstrong Health
  • Oura
  • Pear Therapeutics
  • Roche
  • Sonde Health
  • Vocalis Health
  • Winterlight Labs

Request for Customization:  

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]


Also Visit Our Latest Publication:

Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market Size by 2030

CAR-T Cell Therapies Market 2030

Patient Recruitment and Retention Services Market Trends 2030

mRNA Therapeutics and Vaccines Market Growth By 2030

T-Cell (CAR-T, TCR, and TIL) Therapies Market Analysis and Forecast by 2030


Source : NewsOnFloor

Related Articles

Comments (9)

  • - Aiden Aiden1

    Outstanding article! I want people to know just how good this information is in your article. Your views are much like my own concerning this subject. I will visit daily your blog because I know. It may be very beneficial for me. EMF Protection

  • - Aiden Aiden1

    All your hard work is much appreciated. Nobody can stop to admire you. Lots of appreciation. http aka ms remoteconnect

  • - Aiden Aiden1

    Nice to be visiting your blog once more, it has been months for me. Well this article that ive been waited for therefore long. i want this article to finish my assignment within the faculty, and it has same topic together with your article. Thanks, nice share. restaurant menu prices and hours

  • - Aiden Aiden1

    Best work you have done, this online website is cool with great facts and looks. I have stopped at this blog after viewing the excellent content. I will be back for more qualitative work.

  • - Mauricio Mauricio

    Really We study this the other day however I'd a few ideas about this now I needed to see this once again simply because it's very well crafted. n95

  • - jack son

    Công ty OLANSI là một nhà sản xuất OEM máy lọc không khí chuyên nghiệp, các sản phẩm có chứa máy lọc không khí Trung Quốc, máy lọc không khí gia đình, máy lọc không khí HEPA, máy lọc không khí ion âm, máy lọc không khí ion hóa, máy lọc không khí PM2.5, máy lọc không khí xe hơi, máy lọc không khí trong phòng, máy lọc không khí thông minh và như thế. Máy lọc không khí Olansi

  • - Aiden Aiden1

    It turns out that even the hottest port has a few places where you can get off the beaten path. Here are some recommendations that will make you feel like you're in the know buy weed online

  • - hasnain khatri

    Olansi Healthcare Co., Ltd is a professional manufacturer of air purifier, hydrogen water, water purifier, etc. healthcare, more than 12 years experience since 2009 in Guangzhou, China. 60,000 m2 of our own injection molding factory, our own filter factory, our own mold factory, our own assembly factory! 600 square meters of professional laboratory, 30 engineers R&D team. We are prfessional in ODM, OEM services! 3,000 PCs per day of production capacity! 100% aging test for mass production! CE, CB, ROHS, SASO, CQC, CCC approval and ISO 9001: 2008 certificate! Olansi luftreiniger

  • - joy alex

    Thanks for this, in case of accounts preparation by quickbooks the software got affected by various things such as hosting errors, bugs and errors which doesn't allow sometime to open the login page of the payroll error which can be resolved by the quickbooks update error

Leave a Comment